Teligene Us
Clinical trials sponsored by Teligene Us, explained in plain language.
-
New pill shows promise for rare lung cancer mutations
Disease control Recruiting nowThis study tests a new drug called sutetinib in people with advanced non-small cell lung cancer that has certain uncommon EGFR mutations (L861Q, G719X, or S768I). About 99 participants will take the drug by mouth to see if it shrinks tumors and how safe it is. The goal is to find…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pill targets rare cancer gene in 60-Patient trial
Disease control Recruiting nowThis phase 2 trial is testing a drug called TL118 in 60 adults with advanced solid tumors that have a specific genetic change called an NTRK gene fusion. The drug is taken by mouth and aims to shrink tumors or stop them from growing. The study is currently recruiting participants…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise for rare lung cancer mutations
Disease control Recruiting nowThis study is testing an oral drug called sutetinib maleate in people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal is to see if the drug can shrink tumors and control the disease. About 66 adults will take the drug and be monitored for respo…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC